Document is current

Any future updates will be listed below

Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study

Crossref DOI link: https://doi.org/10.1007/s12094-025-04113-7

Published Online: 2025-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark